Roland Wandeler, PhD, was appointed Chief Executive Officer of Idorsia effective 1 October 2026. He is an experienced biopharmaceutical executive whose career combines scientific expertise with commercial leadership across the global pharmaceutical industry.
Facts compiled by Executive Moves from publicly available news and press releases on 20 July 2026. Spotted an inaccuracy? Email us and we'll review within 1 business day.
To upgrade to a Premium Profile reach out to us at info@executive-moves.com.
Light profile · auto-generated
Are you Roland Wandeler?
This is a Light profile, auto-generated from public news coverage. Claim it to verify your bio, add a photo and links, and control how your career is represented on Executive Moves.
Claim this profile →
